Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FQT1U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,104
Award facts
- Contract value 100% obligated
- $19,103.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,103.52 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls on December 30, 2025, with completion targeted for December 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a widely-used biologic immunosuppressant medication commonly prescribed for rheumatoid arthritis, Crohn's disease, and other autoimmune conditions, and this delivery order represents a single replenishment transaction under a larger contract vehicle.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical prime vendor vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards with the DLA covering specialty medications, brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains in support of Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQT1U?
SPE2DR26FQT1U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FQT1U worth?
The government has obligated $19,104 on SPE2DR26FQT1U.
Is contract SPE2DR26FQT1U an order under another contract?
Yes. SPE2DR26FQT1U is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT1U competed?
The extent of competition for SPE2DR26FQT1U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award